127 related articles for article (PubMed ID: 36995690)
1. Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.
Wang D; Harris J; Kraybill WG; Eisenberg B; Kirsch DG; Ettinger DS; Kane JM; Barry PN; Naghavi A; Freeman CR; Chen YL; Hitchcock YJ; Bedi M; Salerno KE; Severin D; Godette KD; Larrier NA; Curran WJ; Torres-Saavedra PA; Lucas DR
JAMA Oncol; 2023 May; 9(5):646-655. PubMed ID: 36995690
[TBL] [Abstract][Full Text] [Related]
2. Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.
Hallemeier CL; Moughan J; Haddock MG; Herskovic AM; Minsky BD; Suntharalingam M; Zeitzer KL; Garg MK; Greenwald BD; Komaki RU; Puckett LL; Kim H; Lloyd S; Bush DA; Kim HE; Lad TE; Meyer JE; Okawara GS; Raben A; Schefter TE; Barker JL; Falkson CI; Videtic GMM; Jacob R; Winter KA; Crane CH
JAMA Netw Open; 2023 Apr; 6(4):e238504. PubMed ID: 37083668
[TBL] [Abstract][Full Text] [Related]
3. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
4. Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Wang D; Zhang Q; Eisenberg BL; Kane JM; Li XA; Lucas D; Petersen IA; DeLaney TF; Freeman CR; Finkelstein SE; Hitchcock YJ; Bedi M; Singh AK; Dundas G; Kirsch DG
J Clin Oncol; 2015 Jul; 33(20):2231-8. PubMed ID: 25667281
[TBL] [Abstract][Full Text] [Related]
5. Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.
Bedi M; King DM; Shivakoti M; Wang T; Zambrano EV; Charlson J; Hackbarth D; Neilson J; Whitfield R; Wang D
Radiat Oncol; 2013 Mar; 8():60. PubMed ID: 23497372
[TBL] [Abstract][Full Text] [Related]
6. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
[TBL] [Abstract][Full Text] [Related]
7. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
[TBL] [Abstract][Full Text] [Related]
8. Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.
Bell EH; Zhang P; Fisher BJ; Macdonald DR; McElroy JP; Lesser GJ; Fleming J; Chakraborty AR; Liu Z; Becker AP; Fabian D; Aldape KD; Ashby LS; Werner-Wasik M; Walker EM; Bahary JP; Kwok Y; Yu HM; Laack NN; Schultz CJ; Gray HJ; Robins HI; Mehta MP; Chakravarti A
JAMA Oncol; 2018 Oct; 4(10):1405-1409. PubMed ID: 29955793
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H
JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743
[TBL] [Abstract][Full Text] [Related]
10. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.
Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM
Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328
[TBL] [Abstract][Full Text] [Related]
12. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM; Moughan J; Purdy J; Bosch W; Bruner DW; Bahary JP; Lau H; Duclos M; Parliament M; Morton G; Hamstra D; Seider M; Lock MI; Patel M; Gay H; Vigneault E; Winter K; Sandler H
JAMA Oncol; 2018 Jun; 4(6):e180039. PubMed ID: 29543933
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
Mullen JT; Hornicek FJ; Harmon DC; Raskin KA; Chen YL; Szymonifka J; Yeap BY; Choy E; DeLaney TF; Nielsen GP
Cancer; 2014 Dec; 120(23):3676-82. PubMed ID: 25081640
[TBL] [Abstract][Full Text] [Related]
14. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
[TBL] [Abstract][Full Text] [Related]
15. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157
[TBL] [Abstract][Full Text] [Related]
16. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
[TBL] [Abstract][Full Text] [Related]
17. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
[TBL] [Abstract][Full Text] [Related]
19. Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.
Gannon NP; Stemm MH; King DM; Bedi M
J Cancer Res Clin Oncol; 2019 May; 145(5):1321-1330. PubMed ID: 30847552
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD).
Kılıç D; Sert F; Görken İB; Arıcan Alıcıkuş Z; Aktürk N; Kaytan Sağlam E; Kizir A; Özkök S; Yılmaz HT; Göçen F; Yalman D
Turk J Gastroenterol; 2020 May; 31(5):368-377. PubMed ID: 32519956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
